# National Institute for Pharmaceutical Technology & Education Inc.

Canonical: https://abierto.us/vendors/national-institute-for-pharmaceutical-technology-and-education-inc-rkvkgv1cjdb8

- UEI: RKVKGV1CJDB8
- CAGE: 4XQ36
- Location: Minneapolis, MN
- Awards in window: 2 (3 transactions), $1,517,240 obligated, April 9, 2026 to August 20, 2026

## Awarding agencies

- Food and Drug Administration: 2 awards, $1,517,240

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $1,517,240
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75F40126C00054 (definitive contract): $1,517,240, FDA Office of Acq Grant SVCS. Eo 14398 FY26 Baa: National Institute for Pharmaceutical Technology & Education (Baa Fy26c1bp4). https://www.usaspending.gov/award/CONT_AWD_75F40126C00054_7524_-NONE-_-NONE-/
- 75F40122C00192 (definitive contract): $0, FDA Office of Acq Grant SVCS. Mod P00003 - the Purpose of This Modification Is To: the Vendor Requests an Extension of 12 Months for This Project.. https://www.usaspending.gov/award/CONT_AWD_75F40122C00192_7524_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/national-institute-for-pharmaceutical-technology-and-education-inc-rkvkgv1cjdb8.